首页> 外文期刊>International Journal of Clinical Oncology >Effect of gefitinib on warfarin antithrombotic activity
【24h】

Effect of gefitinib on warfarin antithrombotic activity

机译:吉非替尼对华法林抗血栓形成活性的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Despite the literature indicating adverse interactions between warfarin and cytotoxic agents, whether such an interaction occurs when warfarin and gefitinib are used concomitantly is unknown. We analyzed the prevalence of the concomitant use of warfarin and gefitinib, and the incidence of prothrombin time-international normalized ratio (PT-INR) alterations or adverse interactions in concomitant users of warfarin and gefitinib.
机译:尽管有文献表明华法林与细胞毒性剂之间存在不利的相互作用,但尚不清楚在同时使用华法林和吉非替尼时是否发生这种相互作用。我们分析了华法林和吉非替尼同时使用的患病率,以及华法林和吉非替尼的同时使用者中凝血酶原时间-国际标准化比率(PT-INR)改变或不良相互作用的发生率。

著录项

  • 来源
    《International Journal of Clinical Oncology》 |2009年第4期|332-336|共5页
  • 作者单位

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

    Department of Respiratory Medicine Kitasato University School of Medicine 1-15-1 Kitasato Sagamihara Kanagawa 228-0022 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Gefitinib; Warfarin; Drug interaction; Prothrombin time-international normalized ratio; Non-small cell lung cancer;

    机译:吉非替尼;华法林;药物相互作用;凝血酶原时间-国际归一化比率;非小细胞肺癌;
  • 入库时间 2022-08-18 00:10:40

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号